The Multiple Myeloma CAR-T segment shows robust expansion, with the US market estimated at $400 million in 2022 and expected ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Genentech broke ground on a $700 million manufacturing facility in Holly Springs, North Carolina its first on the U.S. East ...

Group14 raises $463 million, South Korea to restructure petrochemicals, AbbVie buys rights to bretisilocin, and more ...